The Gazette49m
This common disorder could be disrupting your sleep
Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
The U.S. Food and Drug Administration (FDA) recently approved Zepbound® (tirzepatide) as the first prescription medication for treating moderate-to-severe obstructive sleep apnea (OSA) in adults with ...
You can't cure sleep apnea but you can manage it — doctors explain how
Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...
Healio1d
The year in obesity: New data on semaglutide and tirzepatide, sarcopenic obesity and more
New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...
Neurology Advisor1d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
Pharmabiz1d
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
STAT2d
First of two major reports on alcohol finds moderate drinking tied to lower mortality
A major report on alcohol’s health effects — which will inform the 2025 Dietary Guidelines for Americans — found moderate drinkers had lower all-cause mortality, and a lower risk of death ...
Hello Healthy: A New Year, New Options for Weight Loss and Better Health
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
Medicare Will Pay for Zepbound for Some Patients. The Costs Could Be Huge.
The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Medicare drug plans can now cover Eli Lilly & Co.'s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that's expected to prove a big boost for the drug company.
ophthalmologyadvisor2d
Patients With Severe OSA Have Reduced Microcirculation of Optic Nerve Head
Decreased blood flow of the optic nerve head (MA, MV, and MT measurements) was significantly correlated with increased OSA ...
Medicare To Cover Eli Lilly's Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment
Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...